This page shows the latest psoriasis news and features for those working in and with pharma, biotech and healthcare.
The approval makes Arcutis’ treatment the first and only topical phosphodiesterase-4 (PDE4) inhibitor approved for plaque psoriasis. ... Moreover, the cream can be used in mild, moderate and severe cases of plaque psoriasis, with no indicated
PsA is a form of arthritis that affects some people who have psoriasis, a disease that causes red patches of skin topped with silvery scales. ... Like psoriasis, psoriatic arthritis is a long-term condition that can get progressively worse.
adalimumab). The latest application comprises all indications covered by the reference medicine, including Crohn’s disease, plaque psoriasis, ulcerative colitis, rheumatoid arthritis and uveitis.
was the first topical novel chemical cream launched for psoriasis patients in the US in 25 years. ... our PSOARING 3 40-week extension efficacy and safety study of Vtama (tapinarof) cream, 1% for adults with plaque psoriasis.
MS is the third therapeutic area to be tackled via Happify Health's unique Sequence approach, in addition to its work in psoriasis and maternal health.
As one of the world's most prevalent skin diseases, psoriasis affects about 60 million people worldwide. ... at keeping psoriasis patients engaged during treatment for psoriasis and improving their quality of life.”.
More from news
Approximately 78 fully matching, plus 303 partially matching documents found.
focus on itch, pain and symptom severity as measured by the patient in the treatment of psoriasis.
Initially we explored the experiences of people with psoriasis. We worked with them to develop and refine the platform based on their digital needs. ... which not only meets the needs of our clients, but the needs of people with psoriasis, who deserve
Hudson had a distinguished career at Novartis, presiding over the launches and roll-outs of psoriasis blockbuster Cosentyx (secukinumab), spinal muscular atrophy gene therapy Zolgensma (onasemnogene abeparvovec) and heart failure therapy
AbbVie needs its new products to deliver quickly, and that includes recently approved JAK inhibitor Rinvoq (upadacitinib) for arthritis and psoriasis therapy Skyrizi (risankizumab) – both tipped as possible future blockbusters despite ... BMS had to
patients on psoriasis drugs for years.
More from intelligence
Approximately 0 fully matching, plus 39 partially matching documents found.
Moukheiber will head the board as it progresses its lead product CT327, a first-in-class selective TrkA kinase inhibitor for the treatment of pruritus (itching) due to psoriasis.
and psoriasis.
of Amgen and Pfizer's big-selling arthritis and psoriasis drug Enbrel (etanercept).
XenoPort will look to Dr Kim's experience as it prepares to advance its drug candidate XP23829, which is being studied as a treatment for psoriasis and/or relapsing forms of
These programmes involve the company's TLR antagonist drug candidates, which Idera says have shown proof-of-concept in clinical trials and are set for further studies in psoriasis and other
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Biopharmaceutical companies are increasingly focusing their attention on developing treatments for these dermatological conditions, with more than 80 products in development to treat atopic dermatitis and psoriasis. ... About FIDE. FIDE is a full-service
Today, there are more than 80 treatments in development for atopic dermatitis and psoriasis.
This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community. Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical
Learn how a Pharma team engaged both dermatologists and patients with psoriasis in two parallel virtual advisory boards. ... 14 dermatologists and 6 patients with psoriasis in two parallel virtual advisory boards.
Suddenly, those with more severe psoriasis had safer and more effective treatment options that delivered the life-changing potential for clear skin. ... The healthcare press has described TYK2 inhibitors as having the potential to revolutionize
More from PMHub
Approximately 14 fully matching, plus 22 partially matching documents found.
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...